Category: Finance
ASX Health Stocks: Starpharma suffers setback as FDA rejects appeal, shares down 10pc
Starpharma suffers setback after US FDA appeal rejected LTR Pharma to commence study on erectile dysfunction nasal spray, SPONTAN Starpharma suffers FDA setback Starpharma [more…]
LTR Pharma firms up study for erectile dysfunction with patient recruitment
LTR Pharma has started patient recruitment for its erectile dysfunction nasal spray SPONTAN® The study will be completed in partnership with Southern Star Research and [more…]
Variscan Mines identifies new drill targets in comprehensive geological assessment of San Jose
Regional structural trends identified in the geological assessment and targeting study indicate significant upside to the current JORC-compliant exploration target for San Jose Varsican says [more…]
School of hard rock: RareX is putting the feelers out for complementary projects to feed wide-open markets
RareX is hunting for projects to feed the European and US markets Cummins Range REE project remains a priority development for the Asian markets Rare [more…]
Top 10 at 11: Rebranding, realigning and getting on top of delays are news today
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning [more…]
Drilling backs Southern Hemisphere’s dream for a resource supporting a 25-year mine life at Llahuin
Final assays highlight potential scale of Southern Hemisphere’s Llahuin copper-gold project Results reinforce belief the Cerro and Ferro deposits are a single mineralised system Broad [more…]
Long Shortz with Galan Lithium: JP says don’t touch that dial
Stockhead’s Ashtyn Hiron sits down with Galan Lithium (ASX:GLN) managing director JP Vargas de la Vega to get the short end of the long story on [more…]
Market Highlights: US inflation jumps again, all eyes on Nvidia, and 5 ASX small caps to watch today
Selloff on Wall Street after higher than expected PPI All eyes will be on Nvidia’s earnings later this week Earnings season also hots [more…]
Iltani Resources unlocks the silver-lead-zinc-indium riches of the Orient
Iltani Resources drilling intersects extensive silver-lead-zinc-indium vein mineralisation Results include some of the ‘highest grade indium drill intersections’ publicly reported on the ASX Orient model [more…]
Dr Boreham’s Crucible: Don’t have a heart attack, CSL’s profit-making ability is in the blood
When announcing disappointing drug trial results, most drug developers take the Bing Crosby approach of accentuating the positive, eliminating the negative and not messing with [more…]
